HIGHLIGHTS
- who: Ruyu Yan and colleagues from the Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Laboratory, Beijing, China Department of Rheumatology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China have published the paper: Successful treatment with bortezomib for refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus, in the Journal: RHEUMATOLOGY AND IMMUNOLOGY RESEARCH Case Report . of May/08,/2022
- what: The authors report a patient with refractory TTP associated with SLE and had a successful treatment with bortezomib. systemic lupus erythematosus. thrombotic thrombocytopenic purpura. bortezomib . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.